These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 10589775

  • 21. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH.
    Oncogene; 2004 Oct 21; 23(49):8135-45. PubMed ID: 15361828
    [Abstract] [Full Text] [Related]

  • 22. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M.
    Cancer Res; 1999 Aug 01; 59(15):3646-51. PubMed ID: 10446976
    [Abstract] [Full Text] [Related]

  • 23. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
    Leroy-Martin B, Peyrat JP.
    Anticancer Res; 1989 Aug 01; 9(3):631-6. PubMed ID: 2764510
    [Abstract] [Full Text] [Related]

  • 24. Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.
    Jomain JB, Tallet E, Broutin I, Hoos S, van Agthoven J, Ducruix A, Kelly PA, Kragelund BB, England P, Goffin V.
    J Biol Chem; 2007 Nov 09; 282(45):33118-31. PubMed ID: 17785459
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The many faces of prolactin in breast cancer.
    Chen WY.
    Adv Exp Med Biol; 2015 Nov 09; 846():61-81. PubMed ID: 25472534
    [Abstract] [Full Text] [Related]

  • 31. Structure and function of a new class of human prolactin antagonists.
    DePalatis L, Almgren CM, Patmastan J, Troyer M, Woodrich T, Brooks CL.
    Protein Expr Purif; 2009 Aug 09; 66(2):121-30. PubMed ID: 19236917
    [Abstract] [Full Text] [Related]

  • 32. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD, Fang H, Xu J, Grimley PM, Rui H.
    Cancer Res; 1998 May 01; 58(9):1914-9. PubMed ID: 9581833
    [Abstract] [Full Text] [Related]

  • 33. Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth.
    Frogne T, Jepsen JS, Larsen SS, Fog CK, Brockdorff BL, Lykkesfeldt AE.
    Endocr Relat Cancer; 2005 Sep 01; 12(3):599-614. PubMed ID: 16172194
    [Abstract] [Full Text] [Related]

  • 34. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
    Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G.
    Cancer Res; 2000 Jun 15; 60(12):3305-12. PubMed ID: 10866325
    [Abstract] [Full Text] [Related]

  • 35. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr 15; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH, Parker CJ, Jordan VC.
    Cancer Res; 1992 Dec 01; 52(23):6539-46. PubMed ID: 1423300
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.